Table 1.
#Term ID | Term Description | False Discovery Rate |
---|---|---|
hsa05213 | Endometrial cancer | 2.20 × 10−20 |
hsa05215 | Prostate cancer | 4.75 × 10−18 |
hsa05200 | Pathways in cancer | 2.24 × 10−17 |
hsa04310 | Wnt signaling pathway | 2.61 × 10−16 |
hsa05226 | Gastric cancer | 2.92 × 10−16 |
hsa04520 | Adherens junction | 3.34 × 10−16 |
hsa05225 | Hepatocellular carcinoma | 7.38 × 10−16 |
hsa05165 | Human papillomavirus infection | 2.76 × 10−15 |
hsa05217 | Basal cell carcinoma | 5.93 × 10−15 |
hsa05206 | MicroRNAs in cancer | 8.70 × 10−15 |
hsa04390 | Hippo signaling pathway | 9.90 × 10−15 |
hsa05210 | Colorectal cancer | 6.99 × 10−14 |
hsa05224 | Breast cancer | 2.64 × 10−13 |
hsa04934 | Cushing’s syndrome | 3.71 × 10−13 |
hsa05216 | Thyroid cancer | 4.14 × 10−13 |
hsa04115 | p53 signaling pathway | 4.94 × 10−13 |
hsa04110 | Cell cycle | 1.55 × 10−12 |
hsa05166 | HTLV-I infection | 4.71 × 10−11 |
hsa04916 | Melanogenesis | 4.15 × 10−10 |
hsa04218 | Cellular senescence | 4.27 × 10−10 |